Arsenic trioxide Injection 1mg/ mL

πŸ’Š Medicine Name:

Arsenic Trioxide

πŸ’‰ Formulation:

Injection, Intravenous (IV) use

πŸ’ͺ Strength:

1 mg/mL
(typically available in a 10 mL vial = total 10 mg per vial)


πŸ“œ Description:

Arsenic trioxide is a cytotoxic agent used mainly in the treatment of Acute Promyelocytic Leukemia (APL). It induces apoptosis and partial differentiation of malignant promyelocytes, especially in patients with the t(15;17) translocation involving the PML-RARΞ± fusion gene.


🧾 Prescription:

Prescription-only medicine (Rx)
Administered only under specialist supervision (typically hematologist/oncologist).


βš™οΈ Mechanism of Action:

  • Promotes apoptosis of leukemia cells.
  • Causes degradation of the PML-RARΞ± fusion protein, correcting the abnormal block in differentiation.
  • Has pro-differentiation and cytotoxic effects depending on dose.

🎯 Indications / Uses:

Primarily used for:

  • Acute Promyelocytic Leukemia (APL):
    • Newly diagnosed, low- to intermediate-risk APL (in combination with ATRA).
    • Relapsed or refractory APL, especially after failure of retinoids and anthracyclines.

πŸ“¦ Common Packaging:

  • 10 mL vial containing 1 mg/mL of arsenic trioxide.
  • Single-dose vial.
  • Labeled as a cytotoxic drug – handle with gloves and proper precautions.

πŸ’‰ Dosage & Administration:

  • Administered intravenously (IV) over 1–2 hours.
  • Typical initial dose (induction phase):
    0.15 mg/kg/day until remission (up to 60 doses).
  • Followed by consolidation cycles (e.g., 25 doses over 5 weeks).
  • Diluted in 100–250 mL of 5% dextrose or saline before administration.
  • Central line recommended to minimize vein irritation.

🧊 Storage:

  • Store at 15–30Β°C (room temperature).
  • Protect from light and freezing.
  • Use immediately after opening – single-use vial.

⚠️ Precautions:

  • QT prolongation β†’ Risk of life-threatening arrhythmias (Torsades de Pointes):
    • Monitor ECG, potassium, magnesium levels.
  • Monitor liver function, renal function, electrolytes, and blood counts.
  • Risk of differentiation syndrome:
    • Fever, weight gain, respiratory distress, pulmonary infiltrates, effusions.
    • Treated with dexamethasone.

πŸ‘¨β€βš•οΈ Patient Advice:

  • You will need regular blood tests and heart monitoring (ECG).
  • Report:
    • Chest pain, palpitations, or shortness of breath
    • Swelling, sudden weight gain, or difficulty breathing
  • Avoid other drugs that prolong the QT interval.
  • Maintain adequate hydration.
  • Female patients must avoid pregnancy; use effective contraception.

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button